Pain & Policy Studies Group, University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.
Palliat Med. 2013 Feb;27(2):105-14. doi: 10.1177/0269216312461973. Epub 2012 Oct 26.
Many international governmental and nongovernmental organizations regard unrelieved cancer pain as a significant global public health problem. Although opioids such as morphine are considered essential medicines in the provision of palliative care and for treating cancer pain, especially when the pain is severe, low- and middle-income countries often lack such medications.
The primary aim of this study was to examine countries' government and health-care system influences on opioid availability for cancer pain and palliative care, as a means to identify implications for improving appropriate access to prescription opioids.
A multivariate regression of 177 countries' consumption of opioids (in milligrams/death from cancer and AIDS) contained country-level predictor variables related to public health, including Human Development Index, palliative care infrastructure, and health system resources and expenditures.
Results were highly explanatory (adjusted R(2) = 82%) and Human Development Index was the most predictive variable when controlling for all other factors in the statistical model (B = 11.875, confidence interval = 10.216, 13.534, p < 0.0001).
Study findings demonstrate that a limited number of predictor variables characterizing a country's government and health-care system infrastructure can explain its opioid consumption level, with the greatest influence being very high Human Development Index. However, Human Development Index is not the most policy-relevant factor, and this finding should be reconciled against the reality that many countries with low or medium Human Development Index have succeeded in creating and sustaining a health-care system to strengthen cancer pain care and palliative care, including through the appropriate use of essential prescription opioids.
许多国际政府组织和非政府组织认为,无法缓解的癌症疼痛是一个重大的全球公共卫生问题。尽管吗啡等阿片类药物被认为是提供姑息治疗和治疗癌症疼痛的基本药物,尤其是在疼痛剧烈时,但中低收入国家往往缺乏此类药物。
本研究的主要目的是研究国家政府和医疗保健系统对阿片类药物治疗癌症疼痛和姑息治疗的可获得性的影响,以确定改善适当获得处方阿片类药物的途径。
对 177 个国家的阿片类药物(癌症和艾滋病死亡人数中的毫克数)消费进行多元回归分析,包含与公共卫生相关的国家层面预测变量,包括人类发展指数、姑息治疗基础设施以及卫生系统资源和支出。
结果具有高度解释性(调整后的 R²=82%),在控制统计模型中所有其他因素的情况下,人类发展指数是最具预测性的变量(B=11.875,置信区间=10.216,13.534,p<0.0001)。
研究结果表明,少数描述国家政府和医疗保健系统基础设施的预测变量可以解释其阿片类药物消费水平,其中最大的影响因素是极高的人类发展指数。然而,人类发展指数并不是最具政策相关性的因素,这一发现应与现实情况相协调,即许多人类发展指数较低或中等的国家已经成功地建立和维持了一个加强癌症疼痛治疗和姑息治疗的医疗保健系统,包括通过适当使用基本处方阿片类药物。